TCM Biotech International Statistics
Total Valuation
TCM Biotech International has a market cap or net worth of TWD 3.66 billion. The enterprise value is 3.21 billion.
Market Cap | 3.66B |
Enterprise Value | 3.21B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | Aug 28, 2024 |
Share Statistics
TCM Biotech International has 59.05 million shares outstanding. The number of shares has increased by 18.23% in one year.
Shares Outstanding | 59.05M |
Shares Change (YoY) | +18.23% |
Shares Change (QoQ) | +3.52% |
Owned by Insiders (%) | 17.60% |
Owned by Institutions (%) | n/a |
Float | 42.81M |
Valuation Ratios
The trailing PE ratio is 179.84 and the forward PE ratio is 45.59.
PE Ratio | 179.84 |
Forward PE | 45.59 |
PS Ratio | 4.31 |
PB Ratio | 3.49 |
P/FCF Ratio | 77.13 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 67.60, with an EV/FCF ratio of 67.59.
EV / Earnings | 160.39 |
EV / Sales | 3.85 |
EV / EBITDA | 67.60 |
EV / EBIT | 121.55 |
EV / FCF | 67.59 |
Financial Position
The company has a current ratio of 6.03, with a Debt / Equity ratio of 0.12.
Current Ratio | 6.03 |
Quick Ratio | 4.68 |
Debt / Equity | 0.12 |
Debt / EBITDA | 2.54 |
Debt / FCF | 2.54 |
Interest Coverage | 11.64 |
Financial Efficiency
Return on equity (ROE) is 2.51% and return on invested capital (ROIC) is 1.77%.
Return on Equity (ROE) | 2.51% |
Return on Assets (ROA) | 1.55% |
Return on Capital (ROIC) | 1.77% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.79 |
Inventory Turnover | 2.18 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.99% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +2.99% |
50-Day Moving Average | 58.53 |
200-Day Moving Average | 56.81 |
Relative Strength Index (RSI) | 70.44 |
Average Volume (20 Days) | 156,426 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TCM Biotech International had revenue of TWD 834.32 million and earned 20.00 million in profits. Earnings per share was 0.34.
Revenue | 834.32M |
Gross Profit | 411.45M |
Operating Income | 26.40M |
Pretax Income | 23.68M |
Net Income | 20.00M |
EBITDA | 43.83M |
EBIT | 26.40M |
Earnings Per Share (EPS) | 0.34 |
Balance Sheet
The company has 573.32 million in cash and 120.64 million in debt, giving a net cash position of 452.68 million or 7.67 per share.
Cash & Cash Equivalents | 573.32M |
Total Debt | 120.64M |
Net Cash | 452.68M |
Net Cash Per Share | 7.67 |
Equity (Book Value) | 1.05B |
Book Value Per Share | 17.75 |
Working Capital | 770.79M |
Cash Flow
In the last 12 months, operating cash flow was 50.30 million and capital expenditures -2.83 million, giving a free cash flow of 47.47 million.
Operating Cash Flow | 50.30M |
Capital Expenditures | -2.83M |
Free Cash Flow | 47.47M |
FCF Per Share | 0.80 |
Margins
Gross margin is 49.32%, with operating and profit margins of 3.16% and 2.40%.
Gross Margin | 49.32% |
Operating Margin | 3.16% |
Pretax Margin | 2.84% |
Profit Margin | 2.40% |
EBITDA Margin | 5.25% |
EBIT Margin | 3.16% |
FCF Margin | 5.69% |
Dividends & Yields
This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 0.46%.
Dividend Per Share | 0.29 |
Dividend Yield | 0.46% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 8.09% |
Buyback Yield | -18.23% |
Shareholder Yield | -17.77% |
Earnings Yield | 0.56% |
FCF Yield | 1.30% |
Stock Splits
The last stock split was on July 20, 2023. It was a forward split with a ratio of 1.0306.
Last Split Date | Jul 20, 2023 |
Split Type | Forward |
Split Ratio | 1.0306 |
Scores
TCM Biotech International has an Altman Z-Score of 10.48.
Altman Z-Score | 10.48 |
Piotroski F-Score | n/a |